A multicenter phase II study (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma

被引：0

作者：

Renner, C. ^{[1
]}

Zinzani, P. L. ^{[2
]}

Gressin, R. ^{[3
]}

Klingbiel, D. ^{[4
]}

Favet, L. ^{[5
]}

Hitz, F. ^{[6
]}

Bargetzi, M. ^{[7
]}

Mingrone, W. ^{[8
]}

Martinelli, G. ^{[9
]}

Trojan, A. ^{[10
]}

Bouabdallah, K. ^{[11
]}

Biaggi, C. ^{[4
]}

Cogliatti, S. ^{[6
]}

Gyan, E. ^{[12
]}

Bertoni, F. ^{[13
,14
]}

Brauchli, P. ^{[4
]}

Ketterer, N. ^{[15
]}

机构：

[1] Univ Zurich, Zurich, Switzerland

[2] Inst Hematol, Bologna, Italy

[3] Univ Hosp, Grenoble, France

[4] SAKK Coordinating Ctr, Bern, Switzerland

[5] Univ Hosp HUG, Geneva, Switzerland

[6] Kantonsspital, St Gallen, Switzerland

[7] Kantonsspital, Aarau, Switzerland

[8] Kantonsspital, Olten, Switzerland

[9] IEO Oncohematol Dept, Milan, Italy

[10] OnkoZentrum Zurich, Zurich, Switzerland

[11] Univ Hosp, Bordeaux, France

[12] Univ Hosp, Tours, France

[13] Oncol Inst So Switzerland IOSI, Expt Oncol Lab, Bellinzona, Switzerland

[14] Lymphoma Unit, Bellinzona, Switzerland

[15] Univ Hosp CHUV, Lausanne, Switzerland

来源：

ONKOLOGIE | 2011年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：97 / 97

页数：1